Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Liquidia Corporation Common Stock (LQDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Liquidia Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Liquidia Corporation Common Stock trades at $34.27 (market cap $3.04B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 2.3× Liquidia Corporation Common Stock's market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Liquidia Corporation Common Stock for 0 Days on average.
| IONS | LQDA | |
|---|---|---|
Market Cap | $7.10B | $3.04B |
Volume | 2,027,457 | 21,111,778 |
Sector | Health | Health |
52-Week High | $86.50 | $91.03 |
52-Week Low | $42.38 | $22.02 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.66B | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →
